Anavex Life Sciences Corp.【AVXL】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
2Q25 -359,378 +15.1%
1Q25 -348,182 +15.4%
4Q24 -336,071 +14.7%
3Q24 -324,451 +14.7%
2Q24 -312,237 +14.9%
1Q24 -301,691 +16.7%
4Q23 -293,069 +19.3%
3Q23 -282,923 +22.3%
2Q23 -271,643 +24.1%
1Q23 -258,536 +24.0%
4Q22 -245,564 +24.3%
3Q22 -231,274 +24.4%
2Q22 -218,907 +24.6%
1Q22 -208,469 +24.4%
4Q21 -197,586 +23.7%
3Q21 -185,868 +20.9%
2Q21 -175,688 +19.3%
1Q21 -167,533 +19.7%
4Q20 -159,678 +19.7%
3Q20 -153,713 +17.0%
2Q20 -147,226 +18.5%
1Q20 -139,989 +20.4%
4Q19 -133,397 +22.5%
3Q19 -131,348 +27.4%
2Q19 -124,274 +23.9%
1Q19 -116,266 +21.7%
4Q18 -108,932 +19.1%
3Q18 -103,139 +19.5%
2Q18 -100,290 +21.2%
1Q18 -95,538 +17.7%
4Q17 -91,479 +17.3%
3Q17 -86,324 +20.7%
2Q17 -82,714 +19.4%
1Q17 -81,165 +20.7%
4Q16 -78,019 +23.3%
3Q16 -71,508 -
2Q16 -69,267 -
1Q16 -67,236 -
4Q15 -63,282 -